BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 News By Date

SuMoTuWeThFrSa
22232425262728
1234567
891011121314
15161718192021
22232425262728
2930311234

 Friday, March 06, 2015
 Top Breaking News
 Featured Stories
 More News
Novartis AG (NVS) Release: FDA Approves First Biosimilar Zarxi (Filgrastim-Sndz) From Sandoz, Inc.
Cytotools AG: European Trials On Diabetic Foot And Ulcus Cruris (Leg Ulcers) On Schedule - Delay In The Market Approval For The Wound Healing Agent Dermapro In India
ViroMed Co., Ltd. dba VM BioPharma: A Phase 2 Study Done At Northwestern Hospital Shows Potential Relief For Diabetics With Painful Condition
St. Jude Children's Research Hospital Release: Chromosomal Rearrangement Is The Key To Progress Against Aggressive Infant Leukemia
A*STAR Scientists Discover New Genes That Influence The Risk Of Developing Leprosy
Lucerne Biosciences Announces Publication Of Claimed Methods For Treating Binge Eating Disorder With Lisdexamfetamine Dimesylate
Calithera Biosciences, Inc. (CALA) Gains Exclusive, Worldwide License To TransTech Pharma, Inc.'s Hexokinase II Inhibitor Program
Midatech Pharma Plc Release: Research Collaboration Signed With Global Pharmaceutical Company
Isis Pharmaceuticals, Inc. (ISIS) Earns $9 Million For Advancing ISIS-SMN Rx In Infants With Spinal Muscular Atrophy
ModiQuest Research And Cellectis (ALCLS) To Collaborate On Antibody Generation For Potential CAR Development
The Michael J. Fox Foundation Release: Leading Research Funders Build On Global Initiative With New Nearly $2 Million Commitment To Study Commonalities Of Neurodegenerative Diseases
Orexo US Launches New 8.6/2.1 Mg ZUBSOLV (Buprenorphine/Naloxone) Sublingual Tablet CIII: 8.6/2.1mg
iBIO Institute’s PROPEL Startups Raise Over $30 Million In 2014, Total Capital Raised Surpasses $140 Million
BioLineRx Ltd. Prices $25 Million Underwritten Public Offering Of Its American Depositary Shares
AEterna Zentaris (AEZS) Announces Pricing Of US$37 Million Public Offering Of Common Shares And Warrants
AEterna Zentaris (AEZS) Announces Proposed Public Offering Of Common Shares And Warrants
BioLineRx Ltd. Announces Underwritten Public Offering Of Its American Depositary Shares
Intra-Cellular Therapies, Inc. Prices $114 Million Public Offering Of Common Stock
AmerisourceBergen Corporation (ABC) Announces Results Of Annual Meeting Of Stockholders
DuPont (DD) Leader Highlights Strategy, Progress And Plans To Accelerate Growth In Advanced Materials And Discusses Near-Term Outlook
Galapagos NV (GLPG.BR) To Be Included In Amsterdam Midcap Index
PhytoTech Medical Limited (ASX:PYL) Investor Presentation
Genovis Introduces A New Service Concept
Company Profile For TransTech Pharma, Inc.
BioLineRx Ltd. Prices $25 Million Underwritten Public Offering Of Its American Depositary Shares
AxoGen, Inc. (AXGN) Reports 61% Revenue Growth For The 2014 Fourth Quarter
Anacor Pharmaceuticals, Inc. (ANAC) Announces 2014 Fourth Quarter And Year-End Financial Results Conference Call And Webcast
AVEO Oncology (AVEO) Reports Full Year 2014 Financial Results
BioLife Solutions, Inc. (BLFS.OB) To Report Fourth Quarter And Full Year 2014 Financial Results And Provide Business Update On March 12, 2015
BioSpecifics Technologies Corporation (BSTC) To Host Conference Call To Report Fourth Quarter And Full Year 2014 Financial Results On Friday, March 13, 2015
Centene Corporation Schedules 2015 First Quarter Financial Results Conference Call
Cellular Dynamics Reports Fourth Quarter And Fiscal Year 2014 Financial Results
Chimerix (CMRX) Announces Fourth Quarter And Full Year 2014 Financial Results
Esperion Therapeutics, Inc. (ESPR) Provides ETC-1002 Development Program Update; Reports Fourth Quarter And Full Year 2014 Financial Results
Fate Therapeutics (FATE) To Webcast Conference Call Reporting Fourth Quarter And Full Year 2014 Financial Results On March 12, 2015
Fibrocell Science, Inc. To Report Fourth Quarter 2014 And Full Year 2014 Financial And Operating Results, And Host Conference Call And Webcast On March 13, 2015
Galena Biopharma  (GALE) Reports Fourth Quarter And Year End 2014 Financial Results
Galapagos NV (GLPG.BR) Reports 2014 Financial Results
Inovio Pharmaceuticals (INO) To Report Fourth Quarter And Year End 2014 Financial Results On March 16, 2015
IRIDEX Corporation (IRIX) Reports 2014 Fourth Quarter, Year-End Results
Oxford BioMedica PLC (OXB.L): Notice of Preliminary Results
Pfenex (PFNX) To Report Fourth Quarter And Full Year 2014 Results And Provide Business Update
Peregrine Pharmaceuticals, Inc. (PPHM) To Report Third Quarter Fiscal 2015 Financial Results After Market On March 12, 2015
Par Pharmaceutical, Inc. Announces Fourth-Quarter And Full-Year 2014 Conference Call
Prothena Reports Fourth Quarter And Full Year 2014 Financial Results And Provides 2015 Financial Guidance And R&D Update
Retrophin (RTRX) Reports Fourth Quarter And Full Year 2014 Financial Results
TetraPhase Pharmaceuticals (TTPH) Reports Fourth-Quarter And Full-Year 2014 Financial Results
Tekmira (TKMR) Conference Call And Webcast Advisory: Corporate Update And Full Year 2014 Financial Results
Vital Therapies, Inc. (VTI) (VTL) Announces Fourth Quarter And Full Year 2014 Financial Results Conference Call With Webcast
WuXi PharmaTech Co., Ltd. Announces Fourth-Quarter and Full-Year 2014 Results
Acceleron Pharma Announces Executive Appointments And Promotions
ESSA Pharma Inc. Announces Appointment Of New Director
Muscular Dystrophy Association Adds Muscle Disease and ALS Leaders to Research Team
Northwestern Medicine Release: Do You Know Fact From Fiction When It Comes To Colorectal Cancer?
Muscular Dystrophy Association Adds Muscle Disease And ALS Leaders To Research Team
Organovo Holdings, Inc.'s Presentations Now Available For On-Demand Viewing At Virtualinvestorconferences.Com
Cell Therapy Catapult: Newcastle Hosts Major Interactive Science Exhibit Exploring The Wonder Of Stem Cells
Novogen Limited (NVGN) Release: Cantrixil Data To Be Presented At Two Major Conferences
XOMA (US) LLC (XOMA) Will Present XOMA 358 Phase 1 Data At ENDO 2015
Fraunhofer USA Center for Molecular Biotechnology Release: New Technologies, New Vaccines Conference Provides Opportunity To Share New Advancements In Combating Emerging Infectious Diseases, Including Ebola
Fraunhofer USA Center for Molecular Biotechnology Release: New Technologies, New Vaccines Conference Provides Opportunity To Share New Advancements In Combating Emerging Infectious Diseases, Including Ebola
BioLineRx Ltd. To Present At The Annual Roth Conference In California
TG Therapeutics, Inc. (MHA) To Present At The 27th Annual ROTH Conference
Hyperion Therapeutics (HPTX) To Present At 27th Annual ROTH Conference
Stemline Therapeutics, Inc. (STML) To Present At The 27th Annual ROTH Conference
Vericel To Present At 27th Annual ROTH Conference
Cytori Therapeutics, Inc. (CYTX) To Provide Corporate Update At The 27th Annual ROTH Conference In Laguna Niguel, California
Senomyx, Inc. (SNMX) To Webcast Corporate Presentation At The The 27th Annual Roth Conference
Alnylam (ALNY) To Webcast Presentation At Barclays Global Healthcare Conference
AbbVie (ABBV) To Present At Barclays Global Health Care Conference
Mylan To Present At The Barclays Global Healthcare Conference
Five Prime Therapeutics, Inc. (FPRX) To Present At The Barclays Global Healthcare Conference
Kite Pharma (KITE) To Present At The 2015 Barclays Global Healthcare Conference
China Establishes Biosimilar Approval Rules; Abandons Drug Price Controls